These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

477 related articles for article (PubMed ID: 34576985)

  • 1. Breath Biomarkers in Diagnostic Applications.
    Pham YL; Beauchamp J
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evolution of clinical and environmental health applications of exhaled breath research: Review of methods and instrumentation for gas-phase, condensate, and aerosols.
    Wallace MAG; Pleil JD
    Anal Chim Acta; 2018 Sep; 1024():18-38. PubMed ID: 29776545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review.
    Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M
    Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exhaled breath testing - A tool for the clinician and researcher.
    Davis MD; Fowler SJ; Montpetit AJ
    Paediatr Respir Rev; 2019 Feb; 29():37-41. PubMed ID: 29921519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volatile organic compounds in cancer and exhaled breath detection technology.
    Zhou X; Qi M; Tang M; Wen S; Xue Z; Wang T
    Adv Clin Chem; 2024; 122():53-114. PubMed ID: 39111965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress and challenges of developing volatile metabolites from exhaled breath as a biomarker platform.
    Chou H; Godbeer L; Allsworth M; Boyle B; Ball ML
    Metabolomics; 2024 Jul; 20(4):72. PubMed ID: 38977623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Driving progress in exhaled breath biomarkers: Breath Biopsy Conference 2019.
    Lawson J; Boyle B; Beauchamp J
    J Breath Res; 2020 Jul; 14(3):030202. PubMed ID: 32662449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On the importance of accurate quantification of individual volatile metabolites in exhaled breath.
    Smith D; Španěl P
    J Breath Res; 2017 Nov; 11(4):047106. PubMed ID: 28635619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breathomics: Review of Sample Collection and Analysis, Data Modeling and Clinical Applications.
    Khoubnasabjafari M; Mogaddam MRA; Rahimpour E; Soleymani J; Saei AA; Jouyban A
    Crit Rev Anal Chem; 2022; 52(7):1461-1487. PubMed ID: 33691552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection?
    Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D
    J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New perspectives on 'Breathomics': metabolomic profiling of non-volatile organic compounds in exhaled breath using DI-FT-ICR-MS.
    Malik M; Demetrowitsch T; Schwarz K; Kunze T
    Commun Biol; 2024 Mar; 7(1):258. PubMed ID: 38431745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lactate in exhaled breath condensate and its correlation to cancer: challenges, promises and a call for data.
    Ruzsányi V; Kalapos MP
    J Breath Res; 2023 Jul; 17(4):. PubMed ID: 37433292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influences of mixed expiratory sampling parameters on exhaled volatile organic compound concentrations.
    Thekedar B; Oeh U; Szymczak W; Hoeschen C; Paretzke HG
    J Breath Res; 2011 Mar; 5(1):016001. PubMed ID: 21383425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors that influence the volatile organic compound content in human breath.
    Blanchet L; Smolinska A; Baranska A; Tigchelaar E; Swertz M; Zhernakova A; Dallinga JW; Wijmenga C; van Schooten FJ
    J Breath Res; 2017 Feb; 11(1):016013. PubMed ID: 28140379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Breath Testing in the Surgical Setting: Applications, Challenges, and Future Perspectives.
    Walsh CM; Fadel MG; Jamel SH; Hanna GB
    Eur Surg Res; 2023; 64(3):315-322. PubMed ID: 37311421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breath volatile organic compounds (VOCs) as biomarkers for the diagnosis of pathological conditions: A review.
    Moura PC; Raposo M; Vassilenko V
    Biomed J; 2023 Aug; 46(4):100623. PubMed ID: 37336362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detecting cancer by breath volatile organic compound analysis: a review of array-based sensors.
    Queralto N; Berliner AN; Goldsmith B; Martino R; Rhodes P; Lim SH
    J Breath Res; 2014 Jun; 8(2):027112. PubMed ID: 24862241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exhaled Breath Analysis for Diabetes Diagnosis and Monitoring: Relevance, Challenges and Possibilities.
    Dixit K; Fardindoost S; Ravishankara A; Tasnim N; Hoorfar M
    Biosensors (Basel); 2021 Nov; 11(12):. PubMed ID: 34940233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular biomarkers in exhaled breath.
    Cikach FS; Dweik RA
    Prog Cardiovasc Dis; 2012; 55(1):34-43. PubMed ID: 22824108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human volatilome: volatile organic compounds (VOCs) in exhaled breath, skin emanations, urine, feces and saliva.
    Amann A; Costello Bde L; Miekisch W; Schubert J; Buszewski B; Pleil J; Ratcliffe N; Risby T
    J Breath Res; 2014 Sep; 8(3):034001. PubMed ID: 24946087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.